Medical Aerosol Inhalers: Past, Present, and Future

The need to deliver pharmaceutical molecules to the respiratory tract has lead to the development of three major types of medical aerosol inhalers: The nebulizer, invented around the turn of the century, which uses aqueous solutions as its atomization substrate; the pressurized metered dose inhaler, invented in the mid-1950s, which uses a finely divided drug in a chlorofluorocarbon propellant suspension; and the dry powder inhaler, first commercialized in the early 1960s, which uses a powdered drug form. In general, these dosage forms have served the medical and patient community well, but recent advances in protein chemistry and the ozone depletion issues related to CFC propellants have lead to a renewed interest in the development of more efficient non-CFC inhalers. This article discusses the history of medical inhaler device technology and highlights the new technologies which may replace some of the existing delivery systems.

[1]  R. Bakis,et al.  Spoken Digit Recognition Using Vowel‐Consonant Segmentation , 1962 .

[2]  R. Jäger-Waldau,et al.  Feasibility of a low dosage dynamic powder dispenser for drug delivery to the lungs. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[3]  S. Newman,et al.  Lung deposition from four nebulizers. , 1993, Respiratory medicine.

[4]  A. Millar,et al.  Improvement of pressurised aerosol deposition with Nebuhaler spacer device. , 1984, Thorax.

[5]  M. O'Doherty,et al.  Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill. , 1990, Thorax.

[6]  M. Molina,et al.  Stratospheric sink for chlorofluoromethanes: chlorine atomc-atalysed destruction of ozone , 1974, Nature.

[7]  J. H. Bell,et al.  Dry powder aerosols. I. A new powder inhalation device. , 1971, Journal of Pharmacy and Science.

[8]  H. Fujisaki,et al.  Temporal organization of segmental features in Japanese disyllables , 1980 .

[9]  M Dolovich,et al.  Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. , 1983, Chest.

[10]  M. Dolovich,et al.  Lung dose, distribution, and clinical response to therapeutic aerosols , 1993 .

[11]  D. Pavia,et al.  Improving the bronchial deposition of pressurized aerosols. , 1981, Chest.

[12]  W Stahlhofen,et al.  Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. , 1980, American Industrial Hygiene Association journal.

[13]  A. Goodwin,et al.  Sodium cromoglycate via inhaler and Autohaler. , 1993, Respiratory medicine.

[14]  S. Clarke,et al.  Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy , 1991 .

[15]  S. Newman,et al.  Effect of different modes of inhalation on drug delivery from a dry powder inhaler , 1994 .

[16]  D. Ganderton,et al.  Performance characteristics of the DeVilbiss Ultraneb 99 ultrasonic nebuliser with reference to use in sputum induction , 1991 .

[17]  G. Salzman,et al.  Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. , 1988, The Journal of allergy and clinical immunology.

[18]  S. Clarke,et al.  Pressurised aerosol deposition in the human lung with and without an "open" spacer device. , 1989, Thorax.

[19]  R. Wolff,et al.  Generation of aerosolized drugs. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[20]  H. Kelly Correct aerosol medication use and the health professions. Who will teach the teachers? , 1993, Chest.